AngioDynamics, Inc. announced the new StarBurst XLi-Enhanced Semi-Flex probe. It is specifically designed to deliver a 7cm ablation of a tumor in a single placement during Computed Tomography-aided procedures.
The Semi Flex XLi-Enhanced probe will allow us to reach and treat tumors that were previously untreatable by percutaneous radiofrequency ablation, said Dr. Kevin Hirsch, Interventional Radiologist and Chairman of the Department of Radiology at Banner Good Samaritan Medical Center. We are very excited for our patients.
The StarBurst series of devices raise the temperature of cells above 45-50°C and causes cellular death. It provides effective treatment options for offer patients with unresectable liver lesions. It is used by surgical oncologists, hepatobiliary surgeons, liver transplant surgeons, laparoscopists and interventional radiologists.
AngioDynamics’ radiofrequency devices have the lowest local tumor recurrence following treatment of all three RFA devices on the US market, said Jan Keltjens, AngioDynamics CEO. This new tool continues to build on our market leadership.
The device gives dynamic, real-time temperature readouts and needle track ablation. Its scalable design can create ablations from 4-7cm, allowing physicians procedural flexibility. An infusion-based system increases conductivity of the ablation zone, and an integrated tubing set allows for easy set up.
The novel device is versatile with both flexible polymer and rigid metal trocar sections. It can be used in percutaneous, laparoscopic and intraoperative procedures. Its ability to bend up to 90 degrees in all directions enables easy gantry entrance for CT systems.